LCOV
HAE icon

London Company of Virginia’s Haemonetics HAE Stock Holding History

London Company of Virginia’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5M Sell
340,574
-12,233
-3% -$786K 0.15% 93
2026
Q1 		$19.9M Buy
352,807
+89,242
+34% +$5.81M 0.12% 100
2025
Q4 		$21.1M Sell
263,565
-2,469
-0.9% -$166K 0.12% 104
2025
Q3 		$13M Sell
266,034
-20,481
-7% -$1.27M 0.07% 111
2025
Q2 		$21.4M Buy
286,515
+10,695
+4% +$708K 0.12% 100
2025
Q1 		$17.5M Sell
275,820
-5,918
-2% -$402K 0.1% 108
2024
Q4 		$22M Buy
281,738
+6,111
+2% +$491K 0.12% 106
2024
Q3 		$22.2M Sell
275,627
-9,873
-3% -$798K 0.12% 103
2024
Q2 		$23.6M Buy
285,500
+106,409
+59% +$9.36M 0.13% 98
2024
Q1 		$15.3M Buy
179,091
+21,579
+14% +$1.69M 0.08% 110
2023
Q4 		$13.5M Sell
157,512
-18
-0% -$1.56K 0.08% 113
2023
Q3 		$14.1M Buy
157,530
+1,710
+1% +$153K 0.08% 102
2023
Q2 		$13.3M Buy
155,820
+984
+0.6% +$83.2K 0.08% 105
2023
Q1 		$12.8M Sell
154,836
-505
-0.3% -$40.9K 0.07% 104
2022
Q4 		$12.2M Sell
155,341
-6,529
-4% -$525K 0.07% 107
2022
Q3 		$12M Sell
161,870
-991
-0.6% -$71.2K 0.08% 105
2022
Q2 		$10.6M Sell
162,861
-808,150
-83% -$47.8M 0.06% 112
2022
Q1 		$61.4M Buy
971,011
+53,653
+6% +$2.92M 0.32% 71
2021
Q4 		$48.7M Sell
917,358
-100,055
-10% -$6.1M 0.25% 75
2021
Q3 		$71.8M Sell
1,017,413
-35,570
-3% -$2.24M 0.39% 66
2021
Q2 		$70.2M Sell
1,052,983
-4,755
-0.4% -$336K 0.37% 70
2021
Q1 		$117M Buy
1,057,738
+117,522
+12% +$14.5M 0.67% 53
2020
Q4 		$112M Buy
+940,216
New +$101M 0.7% 58

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

London Company of Virginia's HAE Position: Q2 2026 in Review

London Company of Virginia reduced its Haemonetics (HAE) stake by 3.5% in Q2 2026, selling an estimated $786K and leaving 340,574 shares worth $25.5M. The position accounts for 0.15% of the portfolio, ranked #93.

London Company of Virginia first reported a position in HAE in Q4 2020 and has held it in 23 quarters since. The position peaked at $117M in Q1 2021. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • London Company of Virginia held 340,574 shares of Haemonetics worth $25.5M as of Q2 2026.
  • London Company of Virginia sold 12,233 Haemonetics shares in Q2 2026, an estimated $786K.
  • Haemonetics made up 0.15% of London Company of Virginia's portfolio in Q2 2026, its #93 holding.
  • London Company of Virginia first reported a position in Haemonetics in Q4 2020 and has held it in 23 quarters since.
  • London Company of Virginia's Haemonetics position peaked at $117M in Q1 2021.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on London Company of Virginia's 13F filing for Q2 2026, filed 14 Aug 2026.